1.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GUS45, ZENITH, NCT00063609
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EUS97, US97, NCT00104104
|
|
3.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EIT04, NCT00219219
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GGR01, NCT00219271
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EDE06, NCT00171964
|
|
6.
|
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CZOL446ECN05, NCT00524849
|
|
7.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603010, UCLA-9911015
|
|
8.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603011, NCT00003884
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603039
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-9908030, NOVARTIS-CZOL4460704, NCI-G00-1722, NCT00005073
|
|
11.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 40 and over
Sponsor: NCI
Protocol IDs: CALGB-79809, NCI-P01-0184, NCT00022087
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-E1A00, NCT00033332, E1A00
|
|
13.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 to 50
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CPMC-IRB-14069, NCI-G02-2127, NOVARTIS-CPMC-IRB-14069, NCT00049452
|
|
14.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NU-02U1, NCT00058188
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SHEFF-AZURE, EU-20315, ISRCTN79831382, BIG-1-04, NCT00072020
|
|
16.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI
Protocol IDs: NCCTG-N03CC, NCT00107263, N03CC, NCCTG N03CC
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-13043, USFIRB#100842, NCT00215943
|
|
18.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 40 to 55
Sponsor: Other
Protocol IDs: 1769-03-A, CZOL446E, NCT00202059
|
|
19.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GUS72, NCT00171639
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446 DE01, NCT00171925
|
|
21.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0308, NCT00301886
|
|
22.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 19 to 59
Sponsor: Other
Protocol IDs: ABCSG-12, CZOL 446 1B 01, Zol-A-01, NCT00295646
|
|
23.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-0518, 0518, NCT00329797
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050136, NCT00321464
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050103, NCT00321620
|
